Veeva APAC Summit

Transforming clinical trials: Unveiling a connected ecosystem for enhanced efficiency and accessibility

In anticipation of the upcoming Veeva APAC Summit on September 4th at ICC Sydney, Eunho Shin, Vice President of Vault R&D Strategy Asia, at Veeva Systems offers an exclusive sneak peek into the evolving landscape of clinical trials.

Reflecting on the monumental impact of COVID-19, Mr Shin highlights the significant shifts in the clinical trial landscape locally in Australia and across the broader Asia Pacific. These changes are reshaping how clinical trials are conducted, managed and accelerated.

Australia’s substantial annual investment of $1.4 billion in industry-sponsored clinical trials is a cornerstone of its economy. However, challenges stemming from the fragmented and siloed ecosystem emphasises the need to streamline operations for more efficient outcomes. Veeva Systems’ versatility in catering to diverse organisations is a key focus of the discussion. From large multinationals to SMEs and hospital networks, Veeva offers tailored solutions to meet unique customer needs, streamlining the clinical trial process with technology.

Considering Australia’s National One Stop Shop consultation report, Mr Shin also discusses how Veeva’s R&D solutions will seek to align with the new approach proposed in the framework, offering insights into potential synergies.

In essence, this interview provides an exploration of the R&D landscape and Veeva Systems’ contributions to reshaping clinical trials and advancing healthcare in Australia and across the Asia Pacific region.

News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.